News

In those cases, each standard deviation increase in VMR was tied to a 50% higher likelihood of experiencing a major adverse ...
Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.
Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...
Theravance Biopharma’s partner Viatris has received China's NMPA approval for Yupelri inhalation solution for maintenance treatment of COPD.
Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.
Background The National Early Warning Score 2 (NEWS2) includes two oxygen saturation scales; the second adjusts target saturations to 88%–92% for those with hypercapnic respiratory failure. Using this ...
A brain abscess is a rare but life-threatening infection. Learn how advances in imaging, surgery, and diagnostics are ...
Navigational bronchoscopy showed similar accuracy to needle biopsy for diagnosing lung nodules, with a markedly lower risk of ...
On the heels of the first pulsed-field ablation device to win approval for atrial fibrillation ablation, a novel version of ...
Shyamali Dharmage grew up in rural Sri Lanka and was inspired to become a doctor after watching the impact of the local ...
Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...
A new PET imaging technique can accurately detect and monitor Mycobacteroides abscessus lung infections—one of the most ...